Sitagliptin: a novel drug for the treatment of type 2 diabetes
On the occasion of the Launching of Gliptin (Sitagliptin) Ultra Medica Pharmaceutical Industries Sponsored Dr. Samir Ouais,MD -Specializes in Endocrinology, Diabetes & Metabolism- and Dr. Khaled M.Hasan, MD -Associate Professor of Pharmacology and Clinical Pharmacology at Damascus University- conference titled "Sitagliptin:a novel drug for the treatment of type 2 diabetes " on 20/01/2010 at Sheraton Hotel in Damascus.
